BXP vs REGN · rev $3.48B vs P/E 14, rev $14.34B
Boston Properties Inc (BXP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BXP currently screens at market cap $12.12B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BXP and REGN stock pages for the full models.
Not investment advice.